Related references
Note: Only part of the references are listed.Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers
Chi-Cheng Huang et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
The clinical value of detecting microcalcifications on a mammogram
Tibor Tot et al.
SEMINARS IN CANCER BIOLOGY (2021)
The current landscape of single-cell transcriptomics for cancer immunotherapy
Puneeth Guruprasad et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Metformin relieves H/R-induced cardiomyocyte injury through miR-19a/ACSL axis - possible therapeutic target for myocardial I/R injury
Cai-Liang Peng et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2021)
Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes
Hongying Zhao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis
Anwar Shams et al.
ONCOGENESIS (2021)
The DNA methylation-regulated MCTP1 activates the drug-resistance of esophageal cancer cells
Lingsuo Kong et al.
Aging-US (2021)
An Overview of PARP Inhibitors for the Treatment of Breast Cancer
Laura Cortesi et al.
TARGETED ONCOLOGY (2021)
CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients
Jianguo Lai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Over-expression of SRD5A3 and its prognostic significance in breast cancer
Yong-ping Zhang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer
Raghuveer Kavarthapu et al.
CANCERS (2021)
KEGG: integrating viruses and cellular organisms
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2021)
Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice
Prasad Dandawate et al.
GASTROENTEROLOGY (2020)
LncTarD: a manually-curated database of experimentally-supported functional lncRNA-target regulations in human diseases
Hongying Zhao et al.
NUCLEIC ACIDS RESEARCH (2020)
Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers
Dhanasekhar Reddy et al.
LIFE SCIENCES (2020)
DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
Vera Constancio et al.
CELLS (2020)
A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer
Yuexian Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Differential regulation of breast cancer bone metastasis by PARP1 and PARP2
Hao Zuo et al.
NATURE COMMUNICATIONS (2020)
Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy
Yuqian Liao et al.
SCIENTIFIC REPORTS (2020)
Multi-gene signature of microcalcification and risk prediction among Taiwanese breast cancer
Hsin-Tien Tsai et al.
SCIENTIFIC REPORTS (2020)
Upregulated CBX8 Promotes Cancer Metastasis via the WNK2/MMP2 Pathway
Yongsheng Jia et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC)
Qicong Mai et al.
Aging-US (2020)
The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment
Szilvia Juhasz et al.
SCIENCE ADVANCES (2020)
Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer
Zhiyuan Wu et al.
THERANOSTICS (2020)
HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation
Soomin Ahn et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2020)
Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma
Li Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Patterns of Genomic Instability in Breast Cancer
Murugan Kalimutho et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
Elizabeth L. Christie et al.
NATURE COMMUNICATIONS (2019)
ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients
Janos T. Fekete et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Mechanisms of Genomic Instability in Breast Cancer
Pascal H. G. Duijf et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21
Dae-Seok Kim et al.
MOLECULAR CELL (2019)
Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis
Xiaoran Long et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation
Anna R. Michmerhuizen et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Identifying chemogenetic interactions from CRISPR screens with drugZ
Medina Colic et al.
GENOME MEDICINE (2019)
ACSL1 Regulates TNFα-Induced GM-CSF Production by Breast Cancer MDA-MB-231 Cells
Reeby Thomas et al.
BIOMOLECULES (2019)
Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia (Comment to Tausch et al.)
Jonathan Weiss et al.
HAEMATOLOGICA (2019)
PARP1 Co-Regulates EP300-BRG1-Dependent Transcription of Genes Involved in Breast Cancer Cell Proliferation and DNA Repair
Maciej Sobczak et al.
CANCERS (2019)
Prolactin modulates TNBC aggressive phenotype limiting tumorigenesis
Vanessa M. Lopez-Ozuna et al.
ENDOCRINE-RELATED CANCER (2019)
A four-mRNA model to improve the prediction of breast cancer prognosis
Lingyu Qi et al.
GENE (2019)
Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers
Maria Panagopoulou et al.
ONCOGENE (2019)
A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications
Anna-Lena Volckmar et al.
GENES CHROMOSOMES & CANCER (2018)
Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature
Yoosup Chang et al.
SCIENTIFIC REPORTS (2018)
Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge
Vincent Goffin
PHARMACOLOGY & THERAPEUTICS (2017)
IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment
Christopher J. Nirschl et al.
CELL (2017)
Cytotoxicity of trans-chalcone and licochalcone A against breast cancer cells is due to apoptosis induction and cell cycle arrest
Luis Felipe Buso Bortolotto et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis
Seung J. Chung et al.
AUTOPHAGY (2017)
Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes
Balazs Gyorffy et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer
Cagri Sakalar et al.
TUMOR BIOLOGY (2016)
TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types
Nanne Aben et al.
BIOINFORMATICS (2016)
Resokaempferol-mediated anti-inflammatory effects on activated macrophages via the inhibition of JAK2/STAT3, NF-κB and JNK/p38 MAPK signaling pathways
Qian Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
Simultaneous suppression of the MAP kinase and NF-κB pathways provides a robust therapeutic potential for thyroid cancer
Koji Tsumagari et al.
CANCER LETTERS (2015)
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
Benjamin G. Bitler et al.
NATURE MEDICINE (2015)
Genome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer
Rohit R. Jadhav et al.
CLINICAL EPIGENETICS (2015)
Involvement of B3GALNT2 overexpression in the cell growth of breast cancer
Taisuke Matsuo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
PARP Inhibitors as P-glyoprotein Substrates
Denise Lawlor et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone
Binghe Xu et al.
BREAST CANCER RESEARCH (2014)
Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer
Louise Maymann Nitze et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Histone Trimethylation of the p53 Gene by Expression of a Constitutively Active Prolactin Receptor in Prostate Cancer Cells
Dunyong Tan et al.
CHINESE JOURNAL OF PHYSIOLOGY (2013)
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer
F. Rojo et al.
ANNALS OF ONCOLOGY (2012)
EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer
Kyung Hyun Yoo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
TRIENNIAL LACTATION SYMPOSIUM: Prolactin: The multifaceted potentiator of mammary growth and function
J. F. Trott et al.
JOURNAL OF ANIMAL SCIENCE (2012)
Immunotherapeutic Potential of Anti-Human Endogenous Retrovirus-K Envelope Protein Antibodies in Targeting Breast Tumors
Feng Wang-Johanning et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases
Chen Xie et al.
NUCLEIC ACIDS RESEARCH (2011)
Androgen Regulation of 5α-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention
Jin Li et al.
PLOS ONE (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair
Peter J. O'Donovan et al.
CARCINOGENESIS (2010)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Genome-wide prioritization of disease genes and identification of disease-disease associations from an integrated human functional linkage network
Bolan Linghu et al.
GENOME BIOLOGY (2009)
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
H. Suzuki et al.
BRITISH JOURNAL OF CANCER (2008)
Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors
Roman L. Bogorad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
Bernard Friedenson
BMC CANCER (2007)
17β-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer
Agneta K. Jansson et al.
CANCER RESEARCH (2006)
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis
J. Veeck et al.
ONCOGENE (2006)
Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells
Z Nouhi et al.
CANCER RESEARCH (2006)
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
T Yamauchi et al.
NATURE (2003)
Non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors
MV Karamouzis et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
WNT pathway and mammary carcinogenesis:: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type
F Ugolini et al.
ONCOGENE (2001)
Share Paper
